A comparison of plasma-free metanephrines with plasma catecholamines in the investigation of suspected pheochromocytoma

Journal of Hypertension

Volumn 29, Issue 12, 2011, Pages 2422-2428

  Lee, Graham R ^a   Johnston, Philip C ^a   Atkinson, A B ^a   McKillop, Derek ^a   Auld, Peter ^a   Hunter, Steven J ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Clonidine suppression test; diagnosis; phaeochromocytoma; plasma catecholamines; plasma metanephrines

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CLONIDINE; DIURETIC AGENT; METADRENALIN; NORADRENALIN; NORMETADRENALIN;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; BLOOD SAMPLING; CANCER SURGERY; CATECHOLAMINE BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CLONIDINE SUPPRESSION TEST; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENDOCRINE FUNCTION TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; PATIENT SELECTION; PHEOCHROMOCYTOMA; PLASMA; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 81355160330     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834c1e68     Document Type: Article

References (20)

1. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005; 366:655-675.
2. Raber W, Raffesberg W, Bischof M, Scheuba C, Niederle B, Gasic S, et al. Diagnostic efficacy of unconjugated plasma metanephrines for the detection of pheochromocytoma. Arch Intern Med 2000; 160:2957-2963.
3. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002; 287:1427-1434.
4. Vá clakik J, Stejskal D, Lacnák B, Lazá rová M, Jedelskỳ L, Kadalová L, et al. Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients. J. Hypertens 2007; 25:1427-1431.
5. Bravo EL, Tarazi RC, Fouad FM, Vidt DG, Gifford RW Jr. Clonidine suppression test: A useful aid in the diagnosis of pheochromocytoma. N Engl J. Med 1981; 305:623-626.
6. McHenry CM, Hunter SJ, McCormick MT, Russell CF, Smye MG, Atkinson AB. Evaluation of the clonidine suppression test in the diagnosis of phaeochromocytoma. J. Hum Hypertens 2011; 25:451-456.
7. Lenz T, Ross A, Schumn-Draeger P, Schulte K-L, Geiger H. Clonidine suppression test revisited. Blood Press 1998; 7:153-159.
8. Unger N, Pitt C, Schmidt IL, Walz MK, Schmid KW, Philipp T, et al. Diagnostic value of various biochemical parameters for the diagnosis of phaeochromocytoma in patients with adrenal mass. Eur J. Endocrinol 2006; 154:409-417.
9. Ross GA, Newbould EC, Thomas J, Bouloux PM, Besser GM, Perrett D, Grossman A. Plasma and 24-h urinary catecholamine concentrations in normal and patient populations. Ann Clin Biochem 1993; 30:38-44.
10. Bouloux P, Perrett D, Besser GM. Methodological considerations in the determination of plasma catecholamines by high-performance liquid chromatography with electrochemical detection. Ann Clin Biochem 1985; 22:194-203.
11. Eisenhofer G, Huynh TT, Hiroi M, Pacak K. Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma. Rev Endocr Metab Disord 2001; 2:297-311.
12. Gerlo EA, Stevens C. Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma: diagnostic value in 19 cases. Clin Chem 1994; 40:25-256.
13. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, et al. Pheochromocytoma: Recommendations for clinical practice from the First International Symposium, October 2005. Nat Clin Pract Endocrinol Metab 2007; 3:92-102.
14. Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JW, Keiser HR, et al. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false positive test results. J. Clin Endocrinol Metab 2003; 88:2656-2666.
15. Boyle JG, Davidson DF, Perry CG, Connell JMC. Comparison of diagnostic accuracy of urinary free metanephrines, vanillyl mandelic acid, and catecholamines and plasma catecholamines for diagnosis of pheochromocytoma. J. Clin Endocrinol Metab 2007; 92:4602-4608.
16. Davidson DF. Phaeochromocytoma with normal catecholamines: The potential value of urinary metadrenalines. Ann Clin Biochem 2002; 39:557-566.
17. Bisschop PH, Corssmit EPM, Baas SJ, Serlie MJ, Endert E, Wiersinga WM, Fliers E. Evaluation of endocrine tests. C: Glucagon and clonidine test in phaeochromocytoma. Neth J. Med 2009; 67:91-95.
18. Bravo EL, Gifford RW. Phaeochromocytoma: diagnosis, localization and management. N Engl J. Med 1984; 311:1298-1303.
19. Grossman E, Goldstein D, Hoffman A, Keiser HR. Glucagon and clonidine testing in the diagnosis of phaeochromocytoma. Hypertension 1991; 17:733-741.
20. Anderson GH Jr, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J. Hypertens 1994; 12:609-615